Abstract:Abstract Background Liver cancer is among the most common malignancy worldwide. Hepatocellular carcinoma (HCC), the principal histological subtype of liver cancer, is globally the third most common cause of cancer-related mortality. The high rates of recurrence and metastasis contribute to the poor prognosis of HCC patients. In recent years, increasing evidence has shown that microRNAs (miRNAs) are involved in the tumorigenesis, progression, and prognosis of HCC. Methods To screen for key candidate miRNAs in HCC, three microarray datasets were downloaded from Gene Expression Omnibus (GEO). The sole common differentially expressed miRNA (DEmiR) observed in the above three datasets using a Venn diagram was microRNA-211-5p (miR-211-5p). The expression of miR-211-5p from HCC tissues was measured in several HCC cell lines. Additionally, using Kaplan–Meier plots, the potential prognostic value of miR-211-5p in HCC was analyzed. Cell counting kit-8 (CCK-8) and transwell assays examined the ability of miR-211-5p to induce cell proliferation, migration, and invasion in HCC cultures. The interaction of miR-211-5p and Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) was assessed both theoretically and using a luciferase reporter assay. Finally, the ability of miR-211-5p to modulate tumorigenesis in HCC in vivo was assessed after establishing a xenograft model. Results qRT-PCR demonstrated that the relative expression of miR-211-5p was considerably down-regulated in HCC tissues and cell lines compared with normal tissue. Kaplan–Meier plots indicated that HCC patients with decreased expression of miR-211-5p had poor overall survival. Upregulation of miR-211-5p in vitro consistently suppressed cell proliferation, migration, and invasion. In contrast, enhanced expression of ACSL4 promoted a malignant phenotype in HCC cells. Importantly, we discovered that ACSL4 was a direct downstream target of miR-211-5p in HCC, and that miR-211-5p suppressed the malignant phenotype by inhibition of ACSL4 expression. Furthermore, miR-211-5p overexpression impaired tumorigenesis and growth of HCC in vivo. Conclusions Targeting miR-211-5p and the downstream gene ACSL4 will possibly provide novel insight and represents a promising approach to future therapy of HCC patients.

MicroRNA-6838-5p Suppresses the Self-Renewal and Metastasis of Human Liver Cancer Stem Cells Through Downregulating CBX4 Expression and Inactivating ERK Signaling

MiR-144-3p-mediated Dysregulation of EIF4G2 Contributes to the Development of Hepatocellular Carcinoma Through the ERK Pathway

Mir-3682-3p Directly Targets FOXO3 and Stimulates Tumor Stemness in Hepatocellular Carcinoma Via a Positive Feedback Loop Involving FOXO3/PI3K/AKT/c-Myc

Mir-589-5p Inhibits MAP3K8 and Suppresses CD90+ Cancer Stem Cells in Hepatocellular Carcinoma

Silencing of Hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation of Microrna-214-3p/ezh2 Axis

miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression

Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

MicroRNA-452 Promotes Stem-Like Cells of Hepatocellular Carcinoma by Inhibiting Sox7 Involving Wnt/β-catenin Signaling Pathway

Mir-217 Targeting DKK1 Promotes Cancer Stem Cell Properties Via Activation of the Wnt Signaling Pathway in Hepatocellular Carcinoma.

Mir-4319 Induced An Inhibition Of Epithelial-Mesenchymal Transition And Prevented Cancer Stemness Of Hcc Through Targeting Foxq1

microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2

Suppression of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells by Krüppel-like Factor 4.

Mir-194 Inhibits Liver Cancer Stem Cell Expansion by Regulating RAC1 Pathway.

Octamer 4/microrna‐1246 Signaling Axis Drives Wnt/β‐catenin Activation in Liver Cancer Stem Cells

MiR-214 Targets Β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma.

MicroRNA‑8063 Targets Heterogeneous Nuclear Ribonucleoprotein AB to Inhibit the Self‑renewal of Colorectal Cancer Stem Cells Via the Wnt/β‑catenin Pathway.

MicroRNA-195 Functions As a Tumor Suppressor by Inhibiting CBX4 in Hepatocellular Carcinoma.

LncRNA HULC regulates hepatocellular carcinoma cell proliferation, apoptosis and epithelial-mesenchymal transition via the miR-372/CXCR4 axis

MicroRNA‑9‑5p Downregulates Klf4 and Influences the Progression of Hepatocellular Carcinoma Via the AKT Signaling Pathway.

MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma.

MicroRNA-1405 p suppresses tumor growth and metastasis by targeting TGFBR 1 and FGF 9 in Hepatocellular carcinoma